Literature DB >> 14609557

Regulation of reduced-folate transporter-1 (RFT-1) by homocysteine and identity of transport systems for homocysteine uptake in retinal pigment epithelial (RPE) cells.

Hany Naggar1, You-Jun Fei, Vadivel Ganapathy, Sylvia B Smith.   

Abstract

Reduced-folate transporter-1 (RFT-1) transports reduced-folates, such as N5-methyltetrahydrofolate (MTF), the predominant circulating form of folate. In RPE, RFT-1 is localized to the apical membrane and is thought to transport folate from RPE to photoreceptor cells. Folate is required for DNA, RNA, protein synthesis and the conversion of homocysteine (Hcy) to methionine. Decreased folate levels are associated with increased Hcy levels. In the present study, we asked whether RFT-1 activity in RPE is altered under high Hcy conditions and examined the transport mechanism for Hcy in RPE. Treatment of ARPE-19 cells, a human RPE cell line, with Hcy at concentrations higher than 50 microM led to a significant decrease in RFT-1 activity. This effect increased as the treatment time increased. The inhibitory effect of Hcy on RFT-1 activity was not non-specific, as the activities of several other nutrient transporters were not affected under identical conditions. The effect of Hcy on RFT-1 was associated primarily with a decrease in the maximal velocity with no detectable change in substrate affinity. The decrease in RFT-1 activity was accompanied by parallel changes in RFT-1 mRNA and protein. Uptake of Hcy in ARPE-19 cells occurred via several transport systems, including Na+-independent systems L and b(0,+) and the Na+-dependent systems B0, ATB(0,+) and A. Studies of the interaction of Hcy with one of the cloned transporters (ATB(0,+)) provided direct evidence for the translocation of Hcy across the membrane via the transporter. We conclude that several transport systems operate in ARPE-19 cells for the entry of Hcy and that high levels of Hcy have deleterious effects on the expression and activity of RFT-1 in these cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609557     DOI: 10.1016/j.exer.2003.08.013

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

1.  Homocysteine transport by systems L, A and y+L across the microvillous plasma membrane of human placenta.

Authors:  Eleni Tsitsiou; Colin P Sibley; Stephen W D'Souza; Otilia Catanescu; Donald W Jacobsen; Jocelyn D Glazier
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

2.  Disturbed visual system function in methionine synthase deficiency.

Authors:  Charlotte M Poloschek; Brian Fowler; Renate Unsold; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-18       Impact factor: 3.117

Review 3.  Homocysteine is transported by the microvillous plasma membrane of human placenta.

Authors:  Eleni Tsitsiou; Colin P Sibley; Stephen W D'Souza; Otilia Catanescu; Donald W Jacobsen; Jocelyn D Glazier
Journal:  J Inherit Metab Dis       Date:  2010-06-22       Impact factor: 4.982

4.  Regulation of reduced-folate transporter-1 in retinal pigment epithelial cells by folate.

Authors:  Hany Naggar; Tracy K Van Ells; Vadivel Ganapathy; Sylvia B Smith
Journal:  Curr Eye Res       Date:  2005-01       Impact factor: 2.424

5.  Molecular and biochemical characterization of folate transport proteins in retinal Müller cells.

Authors:  B Renee Bozard; Preethi S Ganapathy; Jennifer Duplantier; Barbara Mysona; Yonju Ha; Penny Roon; Robert Smith; I David Goldman; Puttur Prasad; Pamela M Martin; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

6.  Homocysteine, system b0,+ and the renal epithelial transport and toxicity of inorganic mercury.

Authors:  Christy C Bridges; Rudolfs K Zalups
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

7.  Transport of thiol-conjugates of inorganic mercury in human retinal pigment epithelial cells.

Authors:  Christy C Bridges; Jamie R Battle; Rudolfs K Zalups
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-23       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.